Michael Woods Selected Research

Hemolysis

2/2002

And hemolysis goes on: ventricular assist device in combination with veno-venous hemofiltration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Woods Research Topics

Disease

11	Neoplasms (Cancer) 05/2022 - 03/2004
10	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 04/2008
4	Pain (Aches) 01/2019 - 03/2004
3	Carcinoma (Carcinomatosis) 04/2022 - 01/2020
3	Margins of Excision 01/2020 - 11/2006
2	Hemorrhage 01/2020 - 01/2018
2	Non-Muscle Invasive Bladder Neoplasms 01/2019 - 01/2019
1	Mycoses (Diseases, Fungus) 02/2024
1	Infections 07/2023
1	Carcinogenesis 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 12/2021
1	Testicular Neoplasms (Testicular Cancer) 10/2021
1	Pathologic Constriction (Stenosis) 11/2020
1	Thrombosis (Thrombus) 01/2020
1	Pulmonary Embolism 01/2020
1	Hypersensitivity (Allergy) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Knee Osteoarthritis 11/2013
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2012
1	Aneurysm (Aneurysms) 02/2011
1	Squamous Cell Carcinoma of Head and Neck 12/2010
1	Transitional Cell Carcinoma 06/2008
1	Intraoperative Complications 02/2008
1	Glucose Intolerance 11/2007
1	Urinary Tract Infections (Urinary Tract Infection) 04/2005
1	Cysts 03/2004
1	Hemolysis 02/2002
1	Wounds and Injuries (Trauma) 02/2002
1	Heart Failure 02/2002

Drug/Important Bio-Agent (IBA)

4	5-aminolevulinic acid hexyl ester FDA Link 01/2022 - 01/2018
2	Immune Checkpoint InhibitorsIBA 05/2022 - 10/2021
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 05/2022 - 10/2021
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2022 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 02/2002
1	Fluconazole (Zonal)FDA LinkGeneric 02/2024
1	Virulence Factors (Pathogenicity Factors)IBA 02/2024
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2019
1	olaparibIBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2019
1	Gemcitabine FDA Link 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Methionine (L-Methionine)FDA Link 01/2017
1	Carbon-11IBA 01/2017
1	Cyclin D1IBA 12/2010
1	Glucose (Dextrose)FDA LinkGeneric 11/2007
1	Blood Glucose (Blood Sugar)IBA 11/2007
1	Hemostatics (Antihemorrhagics)IBA 03/2004
1	Oxidoreductases (Dehydrogenase)IBA 02/2002

Therapy/Procedure

7	Cystectomy 01/2020 - 04/2008
5	Lymph Node Excision (Lymph Node Dissection) 10/2021 - 02/2008
4	Length of Stay 01/2020 - 03/2004
4	Operative Time 06/2008 - 11/2006
3	Catheters 04/2022 - 01/2020
3	Nephrectomy 04/2016 - 03/2004
2	Therapeutics 07/2023 - 02/2002
2	Prostatectomy (Retropubic Prostatectomy) 12/2021 - 02/2008
2	Stents 11/2020 - 04/2005
2	Blood Transfusion (Blood Transfusions) 01/2020 - 03/2004
2	Urinary Diversion (Ileal Conduit) 02/2014 - 01/2012
1	Chemoprevention 01/2023
1	Drug Therapy (Chemotherapy) 10/2021
1	Thrombolytic Therapy 01/2020
1	Thrombectomy 01/2020
1	Embolectomy 01/2020
1	Nephroureterectomy 01/2020
1	Transurethral Resection of Bladder 01/2019
1	Neoadjuvant Therapy 01/2018
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2018
1	Robotic Surgical Procedures 06/2016
1	Warm Ischemia 04/2016
1	Prolotherapy 11/2013
1	Minimally Invasive Surgical Procedures 06/2013
1	Continuous Renal Replacement Therapy 02/2002
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 02/2002
1	Heart Transplantation (Grafting, Heart) 02/2002
1	Heart-Assist Devices 02/2002
1	Hemofiltration 02/2002